ACS CAN: Cancer patients should be exempt from possible Medicaid work requirements

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Centers for Medicare and Medicaid Services issued guidance allowing states to require “able-bodied” adults to work, participate in job training or volunteer in order to receive Medicaid health benefits.

As part of the guidance, CMS exempts children, pregnant women, the disabled and those who are deemed, “medically frail,” however the guidance does not clearly define who would be considered medically frail.

A statement from Chris Hansen, president of the American Cancer Society Cancer Action Network follows:

“Today’s guidance could mean a significant change to one of America’s most essential safety-net programs. Medicaid serves as a vital lifeline that provides health care coverage to more than 2.3 million low-income Americans with a history of cancer.

“Many cancer patients in active treatment are often unable to work or require significant accommodations to their work schedules due to that treatment. It is unclear from the guidance what standards states would use to define “medically frail.”

Research suggests between 40 and 85 percent of cancer patients stop working while receiving cancer treatment, with absences ranging from 45 days to six months. Additionally, evidence shows that patients who have recently completed treatment may need additional time to recover and transition back into the workplace.

“We strongly urge CMS to require states exempt people with serious, complex medical conditions, particularly cancer patients and recent survivors from any work requirements…”

YOU MAY BE INTERESTED IN

 For nearly 30 years, the American Cancer Society’s prostate cancer screening guidelines have advised men to discuss prostate-specific antigen, or PSA, testing with a clinician and weigh potential benefits and harms, rather than treat screening as an unquestioned routine. This “informed decision-making” recommendation was consistent with guidelines from all major professional organizations in the United States, Canada, and Europe. 
For patients with an HPV-related form of throat cancer, treatment is often highly effective, with cure rates as high as 90%, depending on the disease stage. Now, researchers are investigating whether some patients can safely avoid additional treatment while maintaining excellent cancer outcomes.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login